Particle.news

Download on the App Store

UK Nears One Million Users of Weight-Loss Jabs as New Benefits and Risks Emerge

Recent studies highlight health gains like lower blood pressure and reduced alcohol cravings, but experts warn of muscle loss and potential disordered eating.

Image
The pleasure I get from looking in the mirror and seeing a silhouette that is now roughly proportionate and sensible outweighs the shock I get when I take a step or two closer (Photo: Tatsiana Volkava/Getty/Moment RF)
Pregnancy may be an unexpected side effect of weight loss jabs (Photo: Alones Creative/Getty)

Overview

  • Weekly weight-loss injections like semaglutide and tirzepatide mimic gut hormones to curb appetite, with UK usage projected to reach one million this year.
  • Recent trials show these drugs lower systolic blood pressure by an average of 5 mm Hg, comparable to dedicated hypertension medications.
  • Emerging evidence suggests potential benefits for fertility and addiction treatment, including a 40% reduction in alcohol cravings in a small trial.
  • Common side effects include nausea, vomiting, diarrhea, and muscle loss, prompting advice to pair treatments with exercise to preserve muscle mass.
  • Psychologists caution that appetite suppression without proper support may foster disordered eating, urging integrated psychological screening and education.